111 related articles for article (PubMed ID: 37721089)
21. The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal.
Toma W; Kyte SL; Bagdas D; Jackson A; Meade JA; Rahman F; Chen ZJ; Del Fabbro E; Cantwell L; Kulkarni A; Thakur GA; Papke RL; Bigbee JW; Gewirtz DA; Damaj MI
Exp Neurol; 2019 Oct; 320():113010. PubMed ID: 31299179
[TBL] [Abstract][Full Text] [Related]
22. Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.
Naguib M; Xu JJ; Diaz P; Brown DL; Cogdell D; Bie B; Hu J; Craig S; Hittelman WN
Anesth Analg; 2012 May; 114(5):1104-20. PubMed ID: 22392969
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
[TBL] [Abstract][Full Text] [Related]
24. Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy.
Yang X; Jia R; Hu F; Fan W; Lin T; Zhang X; Xu C; Ruan S; Jiang C; Li Y; Pan C; Yang Y; Hu L; Chen Q; Liu WT
Cell Commun Signal; 2023 May; 21(1):99. PubMed ID: 37143083
[TBL] [Abstract][Full Text] [Related]
25. Ghrelin alleviates paclitaxel-induced peripheral neuropathy by reducing oxidative stress and enhancing mitochondrial anti-oxidant functions in mice.
Ishii N; Tsubouchi H; Miura A; Yanagi S; Ueno H; Shiomi K; Nakazato M
Eur J Pharmacol; 2018 Jan; 819():35-42. PubMed ID: 29154935
[TBL] [Abstract][Full Text] [Related]
26. L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding.
Elbrecht A; Chen Y; Adams A; Berger J; Griffin P; Klatt T; Zhang B; Menke J; Zhou G; Smith RG; Moller DE
J Biol Chem; 1999 Mar; 274(12):7913-22. PubMed ID: 10075686
[TBL] [Abstract][Full Text] [Related]
27. Effects of combined chemotherapy and anti-programmed cell death protein 1 treatment on peripheral neuropathy and neuroinflammation in mice.
Livni L; Keating BA; Fiore NT; Lees JG; Goldstein D; Moalem-Taylor G
Pain; 2022 Jan; 163(1):110-124. PubMed ID: 34224494
[TBL] [Abstract][Full Text] [Related]
28. Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment.
Mo M; Erdelyi I; Szigeti-Buck K; Benbow JH; Ehrlich BE
FASEB J; 2012 Nov; 26(11):4696-709. PubMed ID: 22889832
[TBL] [Abstract][Full Text] [Related]
29. Protective Effects of Glatiramer Acetate Against Paclitaxel-Induced Peripheral Neuropathy in Rats: A Role for Inflammatory Cytokines and Oxidative Stress.
Dekamin S; Ghasemi M; Dehpour AR; Ghazi-Khansari M; Shafaroodi H
Neurochem Res; 2024 Apr; 49(4):1049-1060. PubMed ID: 38252396
[TBL] [Abstract][Full Text] [Related]
30. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.
Krukowski K; Eijkelkamp N; Laumet G; Hack CE; Li Y; Dougherty PM; Heijnen CJ; Kavelaars A
J Neurosci; 2016 Oct; 36(43):11074-11083. PubMed ID: 27798187
[TBL] [Abstract][Full Text] [Related]
31. Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy.
Singhmar P; Huo X; Li Y; Dougherty PM; Mei F; Cheng X; Heijnen CJ; Kavelaars A
Pain; 2018 May; 159(5):884-893. PubMed ID: 29369966
[TBL] [Abstract][Full Text] [Related]
32. North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study.
Leal AD; Qin R; Atherton PJ; Haluska P; Behrens RJ; Tiber CH; Watanaboonyakhet P; Weiss M; Adams PT; Dockter TJ; Loprinzi CL;
Cancer; 2014 Jun; 120(12):1890-7. PubMed ID: 24619793
[TBL] [Abstract][Full Text] [Related]
33. Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy.
Zhang H; Boyette-Davis JA; Kosturakis AK; Li Y; Yoon SY; Walters ET; Dougherty PM
J Pain; 2013 Oct; 14(10):1031-44. PubMed ID: 23726937
[TBL] [Abstract][Full Text] [Related]
34. Macrophage Toll-like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice.
Luo X; Huh Y; Bang S; He Q; Zhang L; Matsuda M; Ji RR
J Neurosci; 2019 Aug; 39(35):6848-6864. PubMed ID: 31270160
[TBL] [Abstract][Full Text] [Related]
35. Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy.
Caillaud M; Patel NH; White A; Wood M; Contreras KM; Toma W; Alkhlaif Y; Roberts JL; Tran TH; Jackson AB; Poklis J; Gewirtz DA; Damaj MI
Brain Behav Immun; 2021 Mar; 93():172-185. PubMed ID: 33434562
[TBL] [Abstract][Full Text] [Related]
36. Kappa opioid receptors mediate an initial aversive component of paclitaxel-induced neuropathy.
Meade JA; Alkhlaif Y; Contreras KM; Obeng S; Toma W; Sim-Selley LJ; Selley DE; Damaj MI
Psychopharmacology (Berl); 2020 Sep; 237(9):2777-2793. PubMed ID: 32529265
[TBL] [Abstract][Full Text] [Related]
37. Comparative Analysis of Chemotherapy-Induced Peripheral Neuropathy in Bioengineered Sensory Nerve Tissue Distinguishes Mechanistic Differences in Early-Stage Vincristine-, Cisplatin-, and Paclitaxel-Induced Nerve Damage.
Pollard KJ; Bolon B; Moore MJ
Toxicol Sci; 2021 Feb; 180(1):76-88. PubMed ID: 33410881
[TBL] [Abstract][Full Text] [Related]
38. Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma.
Chiang MC; Chen CM; Lee MR; Chen HW; Chen HM; Wu YS; Hung CH; Kang JJ; Chang CP; Chang C; Wu YR; Tsai YS; Chern Y
Hum Mol Genet; 2010 Oct; 19(20):4043-58. PubMed ID: 20668093
[TBL] [Abstract][Full Text] [Related]
39. Neuroimmune Consequences of eIF4E Phosphorylation on Chemotherapy-Induced Peripheral Neuropathy.
Agalave NM; Mody PH; Szabo-Pardi TA; Jeong HS; Burton MD
Front Immunol; 2021; 12():642420. PubMed ID: 33912169
[TBL] [Abstract][Full Text] [Related]
40. Inducible co-stimulatory molecule (ICOS) alleviates paclitaxel-induced neuropathic pain via an IL-10-mediated mechanism in female mice.
Sankaranarayanan I; Tavares-Ferreira D; Mwirigi JM; Mejia GL; Burton MD; Price TJ
J Neuroinflammation; 2023 Feb; 20(1):32. PubMed ID: 36774519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
